This project has been flagged by a community member as inappropriate due to reason below.*
Expert Interview
Slingshot members are talking to an expert! The topic is:
Discussing how access and pricing are being considered for Zurzuvae (zuranolone).
Ticker(s): SAGEWho's the expert?
Institution: Ascension Health
- Senior Director of Clinical Drug Management and Pharmacy Benefits Programs
- Two decades of experience in clinical drug management and optimizing pharmacy benefits programs for leading healthcare organizations.
- Responsible for overseeing all aspects of formulary management, prior authorization, drug utilization review, and medication therapy management programs.
Interview GoalThe goal of this interview is to discuss a medication used for the treatment of postpartum depression.
Are You Interested In These Questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
